Skip to content

Clinical trials

Breast Neoplasms trials in Hungary

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Country / region: Hungary Clear all

197 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20014
20021
20038
20047
20056
20068
20078
20088
200913
20109
201110
201210
20137
201413
20155
20161
20176
20188
20194
202010
202113
20227
202310
20244
20257
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed123
Active, not recruiting41
Recruiting15
Terminated14
Unknown status2
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche29
AstraZeneca26
Novartis Pharmaceuticals21
Pfizer14
ETOP IBCSG Partners Foundation9
National Institute of Oncology, Hungary8
Eli Lilly and Company6
GlaxoSmithKline6
Sanofi6
Merck Sharp & Dohme LLC5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms197
Neoplasm Metastasis30
Neoplasms13
Ovarian Neoplasms6
Prostatic Neoplasms5
Recurrence5
Triple Negative Breast Neoplasms5
Breast Diseases4
Neutropenia4
Carcinoma, Non-Small-Cell Lung3

Trials

Showing 76 to 100 of 197. Each trial links to its page on Pharma Observatory.

97 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.